News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Medtronic, Inc. Says Can Hit Targets Even if Spine Slows
June 8, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Medtronic Inc said a focus on faster-growth emerging markets will help it hit its financial targets this year even if its sluggish spine and heart rhythm device businesses come up short.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Regulatory
GSK again pulls application for leucovorin, touted by FDA as potential autism treatment
April 10, 2026
·
2 min read
·
Tristan Manalac
Funding
Novartis-backed Sidewinder collects $137M series B to strike at difficult-to-treat tumors
April 9, 2026
·
2 min read
·
Tristan Manalac
C-suite
Novavax Shareholder Vows To Fight CEO Pay Package, End ‘Dogmatic Leadership’
April 8, 2026
·
3 min read
·
Annalee Armstrong
Mergers & acquisitions
Merck Chopped $1B Off Terns’ Offer After Seeing Updated Leukemia Data
April 8, 2026
·
3 min read
·
Tristan Manalac